Research Library

Browse, search, and filter the complete database of verified scientific literature

Topics:
19 results for “dimethyltryptamine”
Year:–
Showing 19 of 176 articles

Filters

Category
Topics
Topics:
Study Type
Year Range
Year:–
Sort By
Neuroscience
NewDOI Resolved

Brain-body integromics of the ayahuasca experience

Madrid-Gambin F, Mallaroni P, Haro N et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026
Neuroimaging study
Pharmacology
PubMed Verified

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects

Abelo A, Smallridge JW, Von Rotz R et al.
Biomedicine & Pharmacotherapy, 2025
Open Access
Pharmacokinetic modeling
Pharmacology
PubMed Verified

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study

Egger K, Jareno Redondo J, Mueller J et al.
Biomedicine & Pharmacotherapy, 2025
5 citationsOpen Access
Randomized controlled trial
Clinical Trials
PubMed Verified

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine

Dornbierer DA, Marten L, Mueller J et al.
Frontiers in Pharmacology, 2023
15 citationsOpen Access
First-in-human trial
Pharmacology
PubMed Verified

Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact

Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM et al.
Pharmaceuticals, 2020
80 citationsOpen Access
Comprehensive review
Depression & Mood
DOI Resolved

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling

Ribeiro GSG, Paranhos BAPB, Dörr F et al.
Frontiers in molecular biosciences, 2026
Open Access
Pharmacokinetic study